189 related articles for article (PubMed ID: 2523284)
1. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
Datiles MB; Fukui H
Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
[TBL] [Abstract][Full Text] [Related]
2. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
3. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
4. The effect of aldose reductase and its inhibition on sugar cataract formation.
Kador PF; Akagi Y; Kinoshita JH
Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
[TBL] [Abstract][Full Text] [Related]
5. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
6. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
Ono H; Nozawa Y; Hayano S
Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
[No Abstract] [Full Text] [Related]
7. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
Mizuno A; Nozawa H; Yaginuma T; Matsuzaki H; Ozaki Y; Iriyama K
Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
[No Abstract] [Full Text] [Related]
8. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
9. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Datiles M; Fukui H; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
Kador PF; Akagi Y; Kinoshita JH
Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
[No Abstract] [Full Text] [Related]
11. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
12. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
13. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
Kojima M; Sasaki K
Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
[No Abstract] [Full Text] [Related]
14. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
15. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
[TBL] [Abstract][Full Text] [Related]
16. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
17. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
Yeh LA; Rafford CE; Beyer TA; Hutson NJ
Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
[TBL] [Abstract][Full Text] [Related]
18. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
Kojima M; Sasaki K
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
[No Abstract] [Full Text] [Related]
19. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
20. Lens metabolism and cellular effects of aldose reductase.
McLean P; Gonzalez AM; Sochor M; Hothersall JS
Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
